South Africa launches second COVID-19 vaccine trial

Current studies show that the Novavax vaccine administered on non-human primates has shown protection against SARS-Cov-2 infection in the nasal passages and lung disease. The University of WITS has launched a second COVID-19 vaccine trial in South Africa by US-based biotech company Novavax. The clinical trial starts on the heels of another vaccine trial which started…